Literature DB >> 21369749

Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

A Jan1, N F Murphy, C O'Loughlin, M Ledwidge, K McDonald.   

Abstract

AIM: To examine the prognostic importance of absolute values and change in values of BNP in patients with stable heart failure (HF).
METHODS: Five-hundred and fifty-nine patients attending a disease management programme were categorized into tertiles of BNP (group 1; ≤ 95 pg/ml, group 2; 96-249 pg/ml and group 3; ≥ 250 pg/ml). A change in BNP between two stable visits was recorded. Patients were followed up for 1 year for death and a composite morbidity measure of HF hospitalization, all-cause hospitalization, unscheduled visits for clinical deterioration(UC) of HF using survival analysis.
RESULTS: The risk of the combined morbidity outcome increased with increasing tertiles of BNP (Log rank = 17.8 (2), p < 0.001). Furthermore, a 50 and 25% increase in BNP predicted morbidity in stable HF patients with an initial BNP > 200 pg/ml (p = 0.02) and > 450 pg/ml (p = 0.03), respectively.
CONCLUSION: In a stable community HF population, an elevated BNP or an increase in BNP predicts an adverse prognosis thereby potentially identifying a population in need of closer clinical follow-up.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369749     DOI: 10.1007/s11845-011-0689-1

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  37 in total

1.  Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

Authors:  Markku S Nieminen; Michael Böhm; Martin R Cowie; Helmut Drexler; Gerasimos S Filippatos; Guillaume Jondeau; Yonathan Hasin; José Lopez-Sendon; Alexandre Mebazaa; Marco Metra; Andrew Rhodes; Karl Swedberg; Silvia G Priori; Maria Angeles Alonso Garcia; Jean-Jacques Blanc; Andrzej Budaj; Martin R Cowie; Veronica Dean; Jaap Deckers; Enrique Fernandez Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; Maria Angeles Alonso Garcia; Kenneth Dickstein; Anibal Albuquerque; Pedro Conthe; Maria Crespo-Leiro; Roberto Ferrari; Ferenc Follath; Antonello Gavazzi; Uwe Janssens; Michel Komajda; João Morais; Rui Moreno; Mervyn Singer; Satish Singh; Michal Tendera; Kristian Thygesen
Journal:  Eur Heart J       Date:  2005-01-28       Impact factor: 29.983

2.  Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.

Authors:  Michiel Rienstra; Isabelle C Van Gelder; Maarten P Van den Berg; Frans Boomsma; Dirk J Van Veldhuisen
Journal:  Europace       Date:  2006-07       Impact factor: 5.214

3.  Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure.

Authors:  Maxime Cournot; Philippe Leprince; Sylvain Destrac; Jean Ferrières
Journal:  Am J Geriatr Cardiol       Date:  2007 Jan-Feb

4.  Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit.

Authors:  Valerio Verdiani; Carlo Nozzoli; Francesca Bacci; Adriana Cecchin; Maria Serena Rutili; Sergio Paladini; Iacopo Olivotto
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

Review 5.  The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.

Authors:  Rory O'Hanlon; Paula O'Shea; Mark Ledwidge; Christina O'Loughlin; Sophie Lange; Carmel Conlon; Dermot Phelan; Sean Cunningham; Ken McDonald
Journal:  J Card Fail       Date:  2007-02       Impact factor: 5.712

6.  Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.

Authors:  Michael Christ; Kirsten Laule-Kilian; Willibald Hochholzer; Theresia Klima; Tobias Breidthardt; Andre P Perruchoud; Christian Mueller
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

7.  B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events.

Authors:  Luis R Castellanos; Vikas Bhalla; Susan Isakson; Lori B Daniels; Meenakshi A Bhalla; Jeannette P Lin; Paul Clopton; Nancy Gardetto; Max Hoshino; Albert Chiu; Robert Fitzgerald; Alan S Maisel
Journal:  J Card Fail       Date:  2008-12-02       Impact factor: 5.712

Review 8.  Natriuretic peptides.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2007-12-18       Impact factor: 24.094

9.  Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine.

Authors:  H C Wijeysundera; M S Hansen; E Stanton; A S Cropp; C Hall; N S Dhalla; J Ghali; J L Rouleau
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

10.  B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.

Authors:  Pascal de Groote; Joël Dagorn; Benoit Soudan; Nicolas Lamblin; Eugene McFadden; Christophe Bauters
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

View more
  1 in total

Review 1.  The use of biomarkers in the patient with heart failure.

Authors:  Punam Chowdhury; Devin Kehl; Rajiv Choudhary; Alan Maisel
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.